Research Grade Tirzepatide Polypeptide Raw Material for Biochemical Experiments

  Product Detail  

1 Core Indications

• Treatment of type 2 diabetes: Effectively reduces fasting blood glucose and postprandial blood glucose, improves insulin sensitivity, and reduces the risk of diabetic complications.
• Chronic weight management of obesity: Promotes fat burning, reduces visceral fat and subcutaneous fat accumulation, and helps obese patients achieve healthy weight loss without obvious rebound.
• Supplementary efficacy: Improves β-cell function, reduces cardiovascular risk, and is suitable for long-term clinical application.

• 2 Mechanism of Action

  Tirzepatide acts as a dual agonist of GLP-1 and GIP receptors, which can simultaneously activate GIPR and GLP1R receptors in the body, exerting a synergistic therapeutic effect:

  • Activates GLP-1 receptor: Promotes insulin secretion, inhibits glucagon secretion, delays gastric emptying, suppresses appetite, and reduces food intake.
  • Activates GIP receptor: Enhances the glucose-lowering effect of GLP-1, promotes fat metabolism, reduces fat accumulation, and improves body composition.

  Clinical data shows that after 52 weeks of use, the weight loss effect of Tirzepatide can reach up to 21.1%, and the blood glucose control effect is stable, which is widely recognized in the medical field.

  
  

  
  

  
  

  About us